Corsair Pharma Announces Positive Phase 1 Results for the TRX-248 Transdermal System in Pulmonary Arterial Hypertension ...

As more and more research hints at the potential therapeutic uses of psychedelics, finding new ways to deliver the powerful drugs has taken on new interest. For example, the active component of ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transdermal Skin Patches Global Market Report 2023" - https://www ...

An innovative delivery method for human immunodeficiency virus medications has been developed through use of a transdermal patch, the first of its kind to treat HIV. An innovative delivery method for ...

Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...

Eight years ago, I wrote about a startup trying to deliver cancer drugs through the skin. That company is long gone, but is the market for so-called transdermal (across the skin) drug delivery a good ...

March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.

It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...

Transdermal matrix-type patches of Nefopam hydrochloride with a combination of pressure-sensitive adhesives were developed. The polymeric composition provided a controlled and sustained release of the ...

It was a severe vitamin D3 deficiency that introduced Yashovardhan Kanodia, 35, co-founder of East Star Financial Advisors in Kolkata to vitamin patches. Racked by aches and pains in his body, he ...

An enhanced instrument for testing drug release from transdermal patches has been developed by Medherant. Medherant, a bioadhesives company formed as a spin-out from the University of Warwick (UK) in ...